Macrolides and lincosamides

Veterinary Dermatology

Volumn 10, Issue 3, 1999, Pages 217-223

  Noli, Chiara ^a,c   Boothe, Dawn ^b  

^a Studio Dermatologico Veterinario   (Italy)

^b TEXAS A AND M UNIVERSITY   (United States)

^c NONE   (Italy)

Author keywords

Cat; Clindamycin; Dog; Erythromycin; Lincomycin; Lincosamides; Macrolides; Pyoderma; Skin; Tylosin

Indexed keywords

BACTERIA (MICROORGANISMS); CANIS FAMILIARIS; FELIS CATUS; STAPHYLOCOCCI;

EID: 0033468763     PISSN: 09594493     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3164.1999.00176.x     Document Type: Article

References (39)

1. Noble, W.C. Bacterial skin infections in domestic animals and man. In: Von Tscharner, C., Halliwell, R.E.W. eds. Advances in Veterinary Dermatology, Vol. 1. London: Ballière Tindall, 1990: 311-26.
2. Spoo, W., Riviere, J. Chloramphenicol. In: Adams, R. ed. Veterinary Pharmacology and Therapeutics. Ames, Iowa: Iowa State University Press, 1995: 820-54.
3. Kapusnik-Uner, J.E., Sande, M.A., Chambers, H.F. Tetracyclines, chloramphenicol, erythromycin and miscellaneous antibacterial agents. In: Hardman, J.G., Limbird, L.E. eds. Goodman and Gilman's the Pharmacologic Basis of Therapeutics, 9th edn. New York: McGraw-Hill, 1996: 1123-54.
4. Hunter, R.P., Lynch, M.J., Ericson, J.F. et al. Pharmacokinetics, oral bioavailability and tissue distribution of azithromycin in cats. Journal of Veterinary Pharmacology and Therapeutics 1995; 18: 38-46.
5. Shepard, R.M., Falkner, F.C. Pharmacokinetics of azithromycin in rats and dogs. Journal of Antimicrobial Chemotherapy 1990; 25(Suppl. A): 49-60.
6. Scott, D.W., Beningo, K.E., Miller, W.H. Jr, Rothstein, E. Efficacy of clindamycin hydrochloride capsules for the treatment of deep pyoderma due to Staphylococcus intermedius infection in dogs. Canadian Veterinary Journal 1998; 39: 753-6.
7. Keane, D.P. Chronic abscesses in cats associated with an organism resembling mycoplasma. Canadian Veterinary Journal 1983; 24: 289.
8. Carro, T., Pedersen, N.C., Beaman, B.L., Munn, R. Subcutaneous absecesses and arthritis caused by probable bacterial L-form in cats. Journal of the American Veterinary Medical Association 1989; 194: 1583-8.
9. Burrows, G.E. Pharmacotherapeutics of macrolides: lincomycins and spectinomycin. Journal of the American Veterinary Medical Association 1980; 176: 1072-7.
10. Pecherau, D., Martel, Ph., Valognes, A., Pedaille, F., Kratz, A. Abcès sous-cutanés et plaies infectées chez le chat. Bactériologie et efficacité clinique de la clindamycine. Pratique Médicale et Chirurgicale Des Animaux de Compagnie 1995; 30: 99-103 (in French).
11. Scott, D.W., Miller, W.H. Jr, Griffin, C.E. Small Animal Dermatology, 5th edn. Philadelphia: W.B. Saunders, 1995: 219.
12. Kwochka, K.W. Recurrent Pyoderma. In: Griffin, C.E., Kwochka, K.W., MacDonald, J.M. eds. Current Veterinary Dermatology. St. Louis: Mosby Year Book, 1993: 3-21.
13. Perret, G., Yin, Y.L., Nicolas, P., Vassy, R., Uzzan, B., Louchahi, M. In vivo effects of macrolides on thyroid hormone serum levels and on hepatic typel, 5'deiodinase in rat. A comparative study with amiodarone, phenobarbital and propanolol. Fundaments in Clinical Pharmacology 1991; 5: 583-93.
14. Harvey, R.G. Tylosin in the treatment of canine superficial pyoderma. Veterinary Record 1996; 139: 185-7.
15. Scott, D.W., Miller, W.H. Jr, Cayatte, S.M., Bagladi, M.S. Efficacy of tylosin tablets for the treatment of pyoderma due to Staphylococcus intermedius infection in dogs. Canadian Veterinary Journal 1994; 35: 617-21.
16. Scott, D.W., Miller, W.H. Jr, Rothstein, S.E., Bagladi, M.S. Further studies on the effciacy of tylosin tablets for the treatment of pyoderma due to Staphylococcus intermedius infection in dogs. Canadian Veterinary Journal 1996; 37: 617-8.
17. Sampson, G.R., Sauter, R.A., Gregory, R.P. Clinical appraisal of tylosin in dogs. Veterinary Medicine Small Animal Clinics 1974; 69: 1259-62.
18. Prost, C., Arfi, L. Utilisation de la lincomycine dans le traitement des pyodermites du chien. Pratique Médicale et Chirurgicale Des Animaux de Compagnie 1993; 28: 495-8 (in French).
19. Littlewood, J.D., Lakhani, K.H., Paterson, S., Wood, J.L.N., Chanter, N. Clindamycin hydrochloride and clavulanate-amoxycillin in the treatment of canine superficial pyoderma: A masked randomised controlled clinical trial. Veterinary Record 1999; 114: 662-5.
20. Piscitelli, S.C., Danziger, L.H., Rodvold, K.A. Clarithromycin and azithromycin: new macrolide antibiotics. Clinical Pharmacology 1992; 11: 137-52.
21. Daniel, R. Azithromycin, erythromycin and cloxacillin in the treatment of infections of skin and associated soft tissues. European Azithromycin Study Group. Journal of Internal Medicine Research 1991; 19: 433-45.
22. Rodriguez-Solares, A., Perez-Gutierrez, F., Prosperi, J., Milagram, E., Martin, A. A comparative study on the efficacy, safety and tolerance of azithromycin, dicloxacillin and flucloxacillin in the treatment of children with acute skin and skin-structure infections. Journal of Antimicrobial Chemotherapy 1993; 31(Suppl. E): 103-9.
23. Mallory, S.B. Azithromycin compared with cephalexin in the treatment of skin and skin structure infections. American Journal of Medicine 1991; 91(Suppl. 3A): 36-39.
24. McDonald, P.J., Pruul, H. Phagocyte uptake and transport of azithromycin. European Journal of Clinical Microbiology and Infectious Diseases 1991; 10: 828-33.
25. Wildfeuer, A., Laufen, H., Muller-Wening, D., Haferkamp, O. Interaction of azithromycin and human phagocytic cells. Uptake of the antibiotic and the effect on the survival of ingested bacteria in phagocytes. Arzneimittelforschung 1989; 39: 755-8.
26. Silvestri, M., Oddera, S., Eftimiadi, C., Rossi, G.A. Azithromycin induces in vitro a time-dependent increase in the intracellular killing of Staphylococcus aureus by human polymorphonuclear leucocytes without damaging phagocytes. Journal of Antimicrobial Chemotherapy 1995; 36: 941-50.
27. Tufano, M.A., de Cipollaro l'Ero, G., Ianniello, R., Baroni, A., Galdiero, F. Antimicrobial agents induce monocytes to release IL-1 alpha, IL-6, and TNF, and induce lymphocytes to release IL-4 and TNF tau. Immunopharmacology and Immunotoxicology 1992; 14: 769-82.
28. Matsuoka, M., Endou, K., Nakajima, Y. Localization of a determinant mediating partial macrolide resistance in Staphylococcus Aureus. Microbiology and Immunology 1990; 34: 643-52.
29. Huovinen, P., Seppala, H., Kataja, J., Klaukka, T. & The Finnish Study Group for Antimicrobial Resistance. The relationship between erythromycin consumption and resistance in Finland. Ciba Foundation Symposium 1997; 207: 36-46.
30. Retsema, J.A., Girard, A.E., Brennan, L.A., Cimochow-ski, C.R., Faiella, J.A. Lack of emergence of significant resistance in vitro and in vivo to the new azalide antibiotic azithromycin. European Journal of Clinical Microbiology and Infectious Diseases 1991; 10: 843-6.
31. Cox, U., Hoskins, J.D., Roy, A.F., Newman, S.S., Luther, D.G. Antimicrobial susceptibility of coagulase-positive staphylococci isolated from Louisiana dogs. American Journal of Veterinary Research 1984; 45: 2039-42.
32. Kruse, H., Hofshagen, M., Thoresen, S.I., Bredal, W.P., Vollset, I., Soli, N.E. The antimicrobial susceptibility of Staphylococcus species isolated from canine dermatitis. Veterinary Research Communications 1996; 20: 205-14.
33. Pedersen-Morner, A., Bergstrom, K., Greko, C., Franklin, A. Antibiotic sensitivity of Staphylococci isolated from cases of canine pyoderma. Compendium on Continuing Education for Practising Veterinarians 1998; 18: 48.
34. Pellerin, J.L., Bourdeau, P., Sebbag, H., Person, J.M. Epidemiosurveillance of antimicrobial compound resistance of Staphylococcus intermedius clinical isolates from canine pyodermas. Compendium of Immunolology, Microbiology and Infectious Diseases 1998; 21: 115-33.
35. Medleau, L., Long, R.E., Brown, J., Miller, W.H. Jr Frequency and antimicrobial susceptibility of Staphylococcus species isolated from canine pyodermas. American Journal of Veterinary Research 1986; 47: 229-31.
36. Phillips, W.E., Williams, B.J. Antimicrobial susceptibility patterns of canine Staphylococcus intermedius isolates from veterinary clinical specimen. American Journal of Veterinary Research 1984; 45: 2376-9.
37. De Saxe, M., Lloyd, D. Antibiotic resistance and other characters of Staphylococcus aureus isolates from dogs. Newsletter and Proceedings of the Association for Veterinary Clinical Pharmacology and Therapeutics 1982; 6: 50-4.
38. Woldehiwet, Z., Jones, J.J. Species distribution of coagulase-positive staphylococci isolated from dogs. Veterinary Record 1990; 126: 485.
39. Noble, W.C., Kent, L.E. Antibiotic resistance in Staphylococcus intermedius isolated from cases of pyoderma in the dog. Veterinary Dermatology 1992; 3: 71-4.